Managing side effects of talquetamab for relapsed/ refractory multiple myeloma: a plain language summary of the MonumenTAL-1 trial
This plain language summary breaks down the side effect management approaches used in the MonumenTAL-1 study, offering a comprehensive look at how researchers and clinicians addressed treatment-related considerations for multiple myeloma patients receiving talquetamab therapy. View the full article Plain Language Summary What is this summary about? This summary describes side effects management in the … Read more